Day 1 CIVM Workshop Session 3: Context of Use Part 1 скачать в хорошем качестве

Day 1 CIVM Workshop Session 3: Context of Use Part 1

Day 1 CIVM Workshop Session 3: Context of Use Part 1 Translational Centers for Microphysiological Systems (TraCe MPS)- Qualifying MPS as Drug Development Tools (DDTs) Presented by Passley Hargrove-Grimes (NIH/NCATS) SUBSCRIBE to C-Path's YouTube Channel Now ►►    / criticalpathinstitute   FOLLOW C-Path: ►LinkedIn:   / c-path   ►Facebook:   / cpathinstitute   ►Twitter: https://twitter.com/CPathInstitute?re About Critical Path Institute C-Path is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org. #CIVM #COUs #MPS #CPath #drugdiscovery #researchgrants #globalhealth #drugdevelopment #datasharing #researchfunding #raredisease #academicresearch #regulatoryscience #globalhealth #consortia #collaboration #FDA #EMA #T1D #Parkinsons #Alzheimers #PKD #Duchenne #ALS #biomarkers